PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)
CUSIP: 74019P207
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.000005 per share
- Shares outstanding
- 24,241,780
- Total 13F shares
- 3,161,323
- Share change
- -2,820
- Total reported value
- $30,774,875
- Price per share
- $9.73
- Number of holders
- 45
- Value change
- -$108,215
- Number of buys
- 17
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74019P207:
Top shareholders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
589,569
|
$7,994,555 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.4%
|
573,052
|
$7,739,067 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2%
|
480,483
|
$6,515,349 | — | 31 Mar 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
1.6%
|
385,440
|
$5,226,566 | — | 31 Mar 2024 | |
| NOVARTIS PHARMA AG |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
12,407,440
|
$4,590,753 | — | 15 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
260,831
|
$3,536,868 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1%
|
250,000
|
$3,390,000 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.47%
|
114,272
|
$1,548,000 | — | 31 Mar 2024 | |
| Derek Jantz |
3/4/5
|
Chief Scientific Officer, Director |
—
mixed-class rows
|
4,079,565
mixed-class rows
|
$1,509,439 | — | 07 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.41%
|
99,498
|
$1,349,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.4%
|
97,275
|
$1,319,049 | — | 31 Mar 2024 | |
| Matthew R. Kane |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
2,026,513
mixed-class rows
|
$749,324 | — | 07 Jun 2021 | |
| Moloney Securities Asset Management, LLC |
13F
|
Company |
0.22%
|
54,199
|
$734,938 | — | 31 Mar 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.16%
|
39,871
|
$540,650 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
29,843
|
$404,767 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
28,413
|
$385,280 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.11%
|
26,402
|
$358,011 | — | 31 Mar 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
0.1%
|
24,767
|
$335,841 | — | 31 Mar 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.08%
|
20,220
|
$274,183 | — | 31 Mar 2024 | |
| Samuel C. Wadsworth |
3/4/5
|
Director |
—
mixed-class rows
|
14,028
mixed-class rows
|
$161,277 | — | 04 Jun 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.05%
|
11,881
|
$161,106 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
11,759
|
$159,452 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.05%
|
11,546
|
$156,564 | — | 31 Mar 2024 | |
| Curi Capital, LLC |
13F
|
Company |
0.05%
|
11,333
|
$153,676 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.04%
|
10,067
|
$137,000 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
8,516
|
$115,476 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.04%
|
8,521
|
$91,345 | — | 31 Mar 2024 | |
| Allworth Financial LP |
13F
|
Company |
0.02%
|
4,769
|
$64,668 | — | 31 Mar 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
0.02%
|
4,675
|
$63,395 | — | 31 Mar 2024 | |
| Alan List |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
5,469
mixed-class rows
|
$56,440 | — | 01 May 2024 | |
| David S. Thomson |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
130,768
mixed-class rows
|
$41,260 | — | 23 Jun 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
2,873
|
$38,958 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,895
|
$25,695 | — | 31 Mar 2024 | |
| Shane Barton |
3/4/5
|
VP & Corporate Controller |
—
mixed-class rows
|
33,562
mixed-class rows
|
$12,418 | — | 07 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
861
|
$11,674 | — | 31 Mar 2024 | |
| Fayaz Khazi |
3/4/5
|
CEO of Elo Life Systems |
—
mixed-class rows
|
65,239
mixed-class rows
|
$8,880 | — | 07 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
389
|
$5,275 | — | 31 Mar 2024 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0%
|
353
|
$4,787 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
206
|
$2,793 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
152
|
$2,061 | — | 31 Mar 2024 | |
| TOTH FINANCIAL ADVISORY CORP |
13F
|
Company |
0%
|
100
|
$1,356 | — | 31 Mar 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
48
|
$644 | — | 31 Mar 2024 | |
| Ameliora Wealth Management Ltd. |
13F
|
Company |
0%
|
33
|
$447 | — | 31 Mar 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
14
|
$190 | — | 31 Mar 2024 | |
| Investors Research Corp |
13F
|
Company |
0%
|
8
|
$108 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
5
|
$68 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
2
|
$27 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1
|
$14 | — | 31 Mar 2024 | |
| GPS Wealth Strategies Group, LLC |
13F
|
Company |
0%
|
1
|
$14 | — | 31 Mar 2024 | |
| Raymond F. Schinazi |
3/4/5
|
Director |
—
class O/S missing
|
156,951
|
— | — | 10 May 2022 |
Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) as of Q2 2024
As of 30 Jun 2024,
PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,161,323 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, TANG CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Aquilo Capital Management, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, and BlackRock Inc..
This page lists
45
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
40
Q2 2024 holders
45
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.